ORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network
Open Access
- 5 April 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (4) , e1008792
Abstract
Pathway level understanding of cancer plays a key role in precision oncology. However, the current amount of high-throughput data cannot support the elucidation of full pathway topology. In this study, instead of directly learning the pathway network, we adapted the probabilistic OR gate to model the modular structure of pathways and regulon. The resulting model, OR-gate Network (ORN), can simultaneously infer pathway modules of somatic alterations, patient-specific pathway dysregulation status, and downstream regulon. In a trained ORN, the differentially expressed genes (DEGs) in each tumour can be explained by somatic mutations perturbing a pathway module. Furthermore, the ORN handles one of the most important properties of pathway perturbation in tumours, the mutual exclusivity. We have applied the ORN to lower-grade glioma (LGG) samples and liver hepatocellular carcinoma (LIHC) samples in TCGA and breast cancer samples from METABRIC. Both datasets have shown abnormal pathway activities related to immune response and cell cycles. In LGG samples, ORN identified pathway modules closely related to glioma development and revealed two pathways closely related to patient survival. We had similar results with LIHC samples. Additional results from the METABRIC datasets showed that ORN could characterize critical mechanisms of cancer and connect them to less studied somatic mutations (e.g., BAP1, MIR604, MICAL3, and telomere activities), which may generate novel hypothesis for targeted therapy.Keywords
Funding Information
- National Institutes of Health (R01LM012011)
- National Institutes of Health (R00LM011673)
- National Cancer Institute (P30CA047904)
This publication has 78 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genesGenes & Development, 2011
- Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytesHepatology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecanThe Pharmacogenomics Journal, 2010
- Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGMBioinformatics, 2010
- Genetic Heterogeneity in Human DiseaseCell, 2010
- Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysisBioinformatics, 2009
- Telomere dysfunction and tumour suppression: the senescence connectionNature Reviews Cancer, 2008
- RETRACTED: Spliceosomal protein E regulates neoplastic cell growth by modulating expression of Cyclin E/CDK2 and G2/M checkpoint proteinsJournal of Cellular and Molecular Medicine, 2008